The 'Wegovy bubble' under the skin: what it is and when it matters

Is the bubble after a Wegovy injection actually a problem?

Most of the time, no. When a subcutaneous injection is given, the medicine is deposited into the fatty tissue just beneath the skin. Occasionally a small amount of fluid gathers at the needle site before it disperses, creating a raised blob that can feel soft or slightly firm. It usually flattens within a few minutes to a few hours. If you want to understand exactly what is happening beneath the surface, our page on the Wegovy bubble under skin explains the physiological response in more detail, including why some people see it more than others. Redness at the site is equally common, particularly in the first few weeks of treatment when your body is adjusting to a new medicine. Some people notice mild bruising too. The NHS semaglutide medicines information lists injection-site reactions (including pain, swelling and redness) among the recognised side effects of Wegovy, and they appear more often at the start or after a dose step-up.

For a fuller picture of how Wegovy works and what to expect during treatment, the Wegovy overview covers the medicine from licence to clinical evidence. The reactions described here rarely require anything more than the technique adjustments below. What matters is knowing which signs fall outside that ordinary range.

What causes the bubble to form in the first place?

A few practical factors make it more likely. Injecting into the same small area week after week is the most common culprit. When tissue is used repeatedly it can thicken slightly (a process called lipohypertrophy) which affects how the medicine disperses and makes visible lumps more likely to linger.

Needle depth matters too. If the needle does not reach the subcutaneous layer properly (too shallow) or passes straight through it into muscle (rare, but possible with very lean abdominal tissue), the medicine lands somewhere it disperses less evenly. Cold medicine also plays a part: injecting semaglutide straight from the fridge is not recommended because cold fluid absorbs more slowly and can pool at the site. The pen should be left to reach room temperature for around 30 minutes before use, always check the Patient Information Leaflet for the exact guidance that applies to your specific pen.

Injecting too quickly and withdrawing the needle before a brief pause can leave a small trail of medicine near the surface. A slow, steady injection followed by holding the pen in place for a moment before removing it gives the tissue time to accept the dose. If you are newer to self-injection, our frequently asked questions cover technique queries that come up regularly.

How should you rotate sites to avoid a recurring bubble?

The licensed injection sites for Wegovy are the abdomen, the front or outer thigh, and the upper arm. Each site covers enough surface area that you can move the injection point by at least a couple of centimetres each week without running out of space. A simple mental map helps: divide the abdomen into a rough grid and work around it over successive weeks, staying clear of the navel and any area that already feels firm or tender from a previous injection.

People who travel or whose weeks do not follow a predictable pattern sometimes find it easier to keep a brief note of last week's site. A quick check on a Monday morning, or whenever payday-weekend plans shift the usual routine, takes seconds and prevents inadvertently returning to the same spot. Some people alternate between the thigh and abdomen entirely to give each area more recovery time between doses.

You can read more about managing the early weeks of treatment on the Wegovy 0.25mg and 0.5mg starter dose page, which covers what the first couple of months typically feel like. When you move beyond those opening months, the Wegovy 2 page sets out what the later dose stages involve and what changes to expect. For context on the clinical evidence behind Wegovy's licensed use, NICE's technology appraisal TA875 provides the official UK assessment.

When does a bubble or lump need medical attention?

Most injection-site bubbles settle without any intervention. The signs that warrant a call to your prescriber or GP are: a lump that does not reduce within 24 to 48 hours; one that grows rather than shrinks; skin that becomes hot, increasingly red or starts weeping; or significant pain that is out of proportion to a normal injection-site reaction. These findings could point to an infection or an abscess, both of which need prompt assessment.

Separately, any symptoms that feel systemic rather than localised (severe stomach pain spreading to the back, difficulty breathing, widespread rash or swelling) are not related to the injection site and require urgent medical attention. The common reasons people pause or stop Wegovy page covers the distinction between manageable side effects and ones that need clinical input.

If you are considering starting semaglutide treatment or would like a prescriber to review a concern mid-treatment, exploring the treatment options available through nume is the natural next step. Every consultation is read by a GPhC-registered prescriber on the same day it is submitted. You can also learn more about how to obtain Wegovy through a regulated UK pharmacy and what the clinical assessment involves. If anything about your current treatment feels off, our team is reachable seven days a week via the contact page.